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This review covers endocarditis due to Pseudomonas aeruginosa, P. maltophilia (9 cases), P. cepacia (16 cases),
Acinetobacter calcoaceticus (20 cases), Moraxella spp. (6 cases), and other nonfermenters. Such endocarditis cases
are very rare and occur chiefly in the setting of drug addiction, on prosthetic or on previously damaged valves.
Nonfermentative gram-negative rods comprise
nonfastidious species of the genera Pseudomonas,
Achromobacter, Alcaligenes, Bordetella, Agrobac-
terium, Flavobacterium, Acinetobacter, Moraxella and
several as yet unnamed taxa. This review focuses on
endocarditis due to these bacteria and thus represents
an update of the last review by Cohen et al. from
19801'1. Overall, these cases are quite rare and
probably account for no more than 1 % of all cases of
endocarditis. Needless to say, correct diagnosis and
susceptibility testing (including supplementation of
Mueller-Hinton broth with Ca and Mg ions) are
important for successful treatment. In the cases
reviewed here, clinical data justified the diagnosis of
endocarditis.
Pseudomonas aeruginosa
This is the most frequently isolated 'nonfermenter'
in the clinical laboratory. Endocarditis is uncommon
(as compared to other infections) except in drug
addicts (80-90%) and following cardiac surgery or
other P. aeruginosa infections (10-20%). In most
European reports on endocarditis1231 as well as in a
recent American review of 104 cases'4) P. aeruginosa
was not reported as an agent of endocarditis.
ENDOCARDITIS IN DRUG ADDICTS1 '•51
From 1967-76, Pseudomonas aeruginosa caused
approximately 5% of all drug-related endocarditis
cases in the United States. In that group it is the most
frequent gram-negative rod (60%). In one series of
nine cases from Detroit, polymicrobial endocarditis in
drug addicts included P. aeruginosa in five'61. In that
city and in Chicago, P. aeruginosa endocarditis seems
to be concentrated. In many respects, the disease
resembles that of Staphylococcus aureus in addicts.
The mean age is below 30 years, men are more
frequently affected than women (6:1) and underlying
valvular disease occurs in less than 20%. The course
is subacute in approximately 70% of the cases, i.e.
when the tricuspid valve is involved. If the left-sided
valves are affected (approximately 20%), the course
tends to be acute. Cutaneous signs and shock are
usually absent. In right-sided disease, embolic cavitary
lung lesions, in left-sided disease, congestive heart
failure and systemic emboli are seen in more than
50%. Treatment for every case should be with an
anti-Pseudomonas penicillin plus an aminoglycoside
at maximal possible doses (checkerboard testing!).
Refractory cases of right-sided endocarditis (approx-
imately 60%) should be treated with valve removal,
while left-sided cases should be operated on immedi-
ately. Mortality rates have decreased lately (70% for
left-sided, 30 % for right-sided disease); they are higher
in patients over 30 years and in mixed infections.
The striking predominance of serotype 11 in
Chicago171 in P. aeruginosa endocarditis (but not in
other infections) should suggest a common source
and/or continued transmission. In Detroit, several
serotypes prevailed151. In Chicago, P. aeruginosa
endocarditis was more frequently associated with the
use of pentazocine and tripelennamine than with
heroin, in striking contrast to S. aureus endocarditis.
The source of the organism seems to be tap water or
other environmental sources; the serotype involved in
cases of endocarditis was found in four out of nine
addict syringes'81.
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ENDOCARDITIS IN NON-ADDICTS
Recent reports of this disease are now quite rare.
The last case collection from 1973|9] lists as risk factors
cardiac surgery, previously damaged valves, antibiotic
treatment and P. aeruginosa infections elsewhere,
notably in the urinary tract. The left side was more
frequently affected than the right side.
Pseudomonas maltophilia
This bacterium, the most frequently isolated 'non-
aeruginosa' Pseudomonas, is ubiquitous in the en-
vironment. The majority of clinical isolates have been
recovered in mixed culture and are, even in blood
cultures, aetiologically indeterminate1101. Bacteraemia
is not an indication of endocarditis. Nine cases, eight
of them reviewed previously'111, are extant in the
literature. All involved previously damaged heart
valves and were associated either with intravenous
drug abuse (four cases) or with open heart surgery
(five cases). The latter were nosocomial and affected,
like three cases in drug addicts, prosthetic valves with
early or late infections and one congenital ventricular
septal defect"21. One case showed a mixed culture with
viridans streptococci, probably caused by blood reflux
from a contaminated collection tube'111. The patients'
mean age was 36 years (range 25-65); seven were
males and two females. Three patients died; the others
recovered with either medical or medical-surgical
treatment (three cases each). The mitral valve was
affected in six cases, the aortic in two cases, and both
in one case. Other data are fragmentary. Possible
sources were not traced. Treatment was tried with
chloramphenicol, aminoglycosides, carbenicillin, tri-
methoprim-sulphamethoxazole, and polymyxin B
and mixtures thereof; at present, the most promising
in vitro combination against P. maltophilia seems to
be trimethoprim-sulphamethoxazole plus carbenicil-
lin, possibly supplemented with rifampin'111.
Pseudomonas cepacia
This organism is not uncommonly a contaminant
of the moist hospital environment (instruments, water
sources, flower vases, solutions and some disinfec-
tants, notably quaternary ammonium compounds)
and is able to survive under conditions of minimal
nutrition'101. Its pathogenic significance in blood
cultures is definitely higher than that of P. maltophilia.
Since the last review of 16 cases'111, no new report of
P. cepacia endocarditis has appeared. Notable
features of these cases were as follows: 14 patients were
* Erroneously counted as 15 cases in [1],
male, 12 were drug addicts, eight showed previous
valve damage (four had prosthetic valves); the mean
age was 37 years (range 23-66 years), two had mixed
cultures and nine died. The course was acute to
chronic. In five cases the tricuspid valve was affected;
in the remainder, the left heart valves were affected
about equally. Potential sources were not traced.
Treatment was quite difficult because of the innate
multiple resistance of the organism; therapy with a
combination of trimethoprim-sulphamethoxazole
(SXT) plus polymyxin was successful in six patients
who, with the exception of one patient, eventually
needed valve replacement. Notable was the emergence
of SXT-resistant variants in two patients during
treatment.
Acinetobacter calcoaceticus
This organism is also ubiquitous, particularly on
human skin and in the upper respiratory tract1131.
Many blood culture isolates are clinically
insignificant'131. The previous review'1' lists nine cases
of endocarditis due to A. calcoaceticus. We were able
to count 20, some of which were incompletely
documented'14 22]. The ssp. (var.) anitratus was
involved in nine cases, the ssp. Iwoffii in 10 cases, one
case was not subspeciated. Conspicuous were a low
mean age (26 years, range 4-60) due to five cases in
children114-1820', only one proven case each of drug
addiction and mixed culture (unrelated'1221), involve-
ment of prosthetic valves in 25 % (three early, two late
cases) and previous rheumatic valve damage in 33%.
The aortic valve alone was affected in 38%, the mitral
valve in 31 % and both in 25 % . There was no tricuspid
involvement. Thirty percent of the patients died.
Possible sources were not further identified. The
course varied from acute to chronic. There was no
discernible difference in these characteristics between
the two subspecies. Data on treatment are fragmen-
tary; a combination of a betalactam antibiotic and an
aminoglycoside may be the best. These data differ
considerably from the previous review'1'.
Moraxella spp.
The previous review'11 lists four cases of endocar-
ditis, two of which, however, were caused by Kingella
kingae. We found a total of six cases'2328 ' which were
quite heterogeneous and incompletely documented.
Moraxellae are part of the normal flora of the upper
respiratory tract. Their presence in blood cultures is,
in our experience, usually of no clinical significance.
Three cases were due to the species M. nonliquefaciens,
and one each to the species M. liquefaciens, M.
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osloensis, and M6. The ages of the patients varied
between childhood and 77 years. Two patients had
mitral valve prolapse, two had prosthetic valves and
one had congenital heart disease. The courses were
acute to chronic. No drug addiction was involved.
Treatment was with ampicillin, in some cases plus an
aminoglycoside. Two patients needed prosthetic
valves and two died.
Other nonfermenters
One case of endocarditis each due to P. stutzerfl29],
CDC group VE-1'301, P. alcaligenes^, and two each
due to Flavobacterium meningosepticum^32-33^ and
Bordetella bronchiseptical29M] (the latter mixed) have
been reported. No general conclusion can be drawn.
Special mention must be made of endocarditis due
to Alcaligenes faecalis. This organism could not be
identified with accuracy until the 1970s; thus, these
reports'1535"3" must remain speculative as to the true
character of the organism.
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Note added in proof
Three papers on P. aeruginosa endocarditis appeared after
this paper had been submitted. One:
Botsford KB, Weinstein RA, Nathan CR, Kabins SA.
Selective survival in pentazocine and tripelennamine of
Pseudomonas aeruginosa serotype Oil from drug addicts.
J Infect Dis 1985; 151:209-15
reported the selective survival advantage of P. aeruginosa
Ol 1 in media containing tripelennamine. Another:
Wieland M, Lederman MM, Kline-King C et al. Left-sided
endocarditis due to Pseudomonas aeruginosa. A report of 10
cases and review of the literature. Medicine 1986; 65: 180-9
added 10 more cases to the literature, eight of them in addicts
from Cleveland, Ohio, and reviewed the English literature.
The third:
Jimenez-Lucho VE, Saravolatz LD, Medeiros AA, Pohlod
D. Failure of therapy in Pseudomonas endocarditis: selection
of resistant mutants. J Infect Dis 1986; 154: 64-8
reported on the failure of piperacillin-tobramycin treatment
in two cases of P. aeruginosa endocarditis which was
explained by the selection of high-level beta-Iactamase
producers in a large bacterial inoculum.
